Elbow Lesion Market driven by Growing Medical Research Sector worldwide | Key Players, Share, Trends, Applications, Forecast up to 2026

Elbow lesion is an Elbow disorder that mainly affects arms muscles, elbow ligaments, tendons, and bones in the arm and this can be caused by overuse of elbow and sports injuries that can cause various elbow conditions. Golfers, Baseball pitchers, tennis players, and boxers are most susceptible to elbow disorders. Different types of elbow disorders are medial epicondylitis, lateral epicondylitis, olecranon bursitis, osteoarthritis, dislocation or fracture of the elbow, ligaments strains and sprains, and osteochondritis dissecans. Elbow disorders can be diagnosed by using physical examination such as x-rays, computerized tomography scans, magnetic resonance imaging, electromyography, and biopsy of bursa fluid.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/96

Growing geriatric population and rising number of sports-related injuries are augmenting the market growth of elbow lesion

Growing prevalence of elbow tendon, rising incidence of elbow joint pain, and increasing healthcare investment are some of the factors driving the growth of the global market for elbow lesion. According to the National Institute for Health and Care Excellence (NICE) tennis elbow was prevalent in 1%-3% of the UK population in 2012. It has been observed that people above 60 years are more suffering with elbow pain. Therefore, the rapidly increasing geriatric population and rising incidence of arm fracture caused due to accidents are expected to drive the growth of the elbow lesion market in the near future.

Platelet-rich plasma – A highly effective antidote for tennis elbow

The elbow lesion market is classified on the basis of treatment methods into surgical and non-surgical therapies. Arthroscopic surgery and open surgery are types of surgical therapies performed. Non-surgical therapies comprise drugs and physical therapy.

Various non-steroidal anti-inflammatory drugs (NSAIDS) such as ibuprofen, aspirin, and cortisone are administered for pain management. Botulinum toxin and hyaluronate are some of the other drugs. Platelet-rich plasma (PRP), a novel technique, is being preferred for the treatment of tennis elbow.  Physical therapies such as muscle stimulation and ice massage are used to improve the healing process.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/96

The rising number of sports injuries drives the growth of the elbow lesion market in North America

The rising number of sports events and competitions in the U.S, good medical facilities, and favorable reimbursement policies are some of the major factors fueling the growth of the elbow lesion market. Elbow injuries are considered to be an expected consequence of throwing sports.  According to a study published in the Orthopaedic Journal of Sports Medicine in 2013, 30% of baseball players will have elbow pain every year, and nearly 60% of players with elbow pain will show radiographic abnormalities. The elbow lesion market in emerging markets such as India, China, Russia, and Brazil is growing due to the growing number of sports injuries in these regions, the use of advanced technology in diagnosis, and rising spending by the government for improving medical facilities.

Key players

Key manufacturers of elbow braces for athletes include Mueller Sports Medicine and Professional Orthopedic Products, among others.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/elbow-lesion-market-96

Key Developments

• Major institutes are focused on conducting research related to elbow lesion and related conditions. For instance, in September 2019, a research by the Lutheran University of Brazil that was published in the Journal of Shoulder and Elbow Surgery found that Iontophoresis proved to be an effective technique in reducing pain and improving strength and function in individuals with tennis elbow.
• In July 2019, a Hallym University Sacred Heart Hospital study found that the use of an additional 70° arthroscope did not provide a significant improvement in the outcomes of arthroscopic débridement for chronic recalcitrant tennis elbow.
• In January 2019, researchers from Hospital Universitario Virgen del Rocío, Spain, found that ultrasound-guided treatment with botulinum toxin (incobotulinumtoxina) in patients with lateral epicondylitis may be an effective treatment approach in the appropriate patient population.

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.